January 15, 2025 - 15:53

Second Avenue Capital Partners, in collaboration with Alpha Wave Global and Sagard Credit, has successfully closed a series of credit facilities aimed at financing the acquisition of the renowned denim brand, True Religion. This strategic move marks a significant step in the revitalization of True Religion, a label known for its premium denim and distinctive designs.
The partnership between these financial entities underscores a commitment to supporting the brand's growth trajectory. With the infusion of capital, True Religion is poised to enhance its market presence and possibly expand its product offerings. The financing arrangement is expected to provide the necessary resources for operational improvements and marketing initiatives.
As the retail landscape continues to evolve, securing such financial backing is crucial for brands like True Religion that aim to navigate challenges and capitalize on new opportunities. This acquisition is anticipated to not only benefit the brand but also contribute positively to the overall market dynamics in the fashion industry.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...